I really don't know either Peace. The only thing I'm leaning towards, is perhaps the EET technology wasn't perfected in time for Janssen's timelines/objectives?? Why would the company state that they will next focus on advancing the technology to demonstrate that they can successfully deliver therapeutic classes of drugs inside cells for new commercial partners? AND that the work to date with Janssen will now provide them with the scientific ammunition for a broader range of collaborations? Believe me, I'm scratching my head on this one too.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)